Fora Capital, LLC Biogen Inc. Transaction History

Fora Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$212.02 - $267.71 $6.07 Million - $7.67 Million	28,652 New	28,652 $6.18 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $1.62 Million - $1.88 Million	5,903 New	5,903 $1.68 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $4.87 Million - $6.72 Million	25,017 New	25,017 $6.68 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $512,776 - $658,993	-2,290 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.15 Million - $2.8 Million	-7,599 Reduced 76.84%	2,290 $648,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $2.26 Million - $3.63 Million	8,743 Added 762.91%	9,889 $3.42 Billion
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $2.37 Million - $2.78 Million	-9,764 Reduced 89.5%	1,146 $321 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $2.5 Million - $3.76 Million	10,577 Added 3176.28%	10,910 $2.67 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $88,168 - $101,801	333 New	333 $94 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.87 Million - $2.48 Million	-7,234 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $481,510 - $610,802	-1,791 Reduced 19.84%	7,234 $2.29 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.99 Million - $2.74 Million	9,025 New	9,025 $2.68 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.